Bioreperia Cro

BioReperia has developed a technique to predict how cancer patients respond to anti-cancer treatment. In only five days, we can test how cells from each patient´s tumor respond to the different drugs offered to the patient, providing better treatment and more efficient healthcare. This technique is already on the market for pharma companies where they can evaluate how efficient new cancer treatments are, much faster, cheaper, and translational than the current techniques available.